NVAX

#1722
Novavax, Inc. - Common Stock
10.9 7 USD
+6.30%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
10.97
10.97
Range Annuel
6.13
11.97
Changement quotidien
+6.30%
Changement Mensuel
+36.95%
Evolution sur 6 mois
+60.15%
Changement Annuel
+54.94%
Clôture Précédente
10.3 2
Open
10.9 7
Low
10.9 7
High
10.9 7
Volume
127
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025 TTM

Novavax, Inc. - Common Stock

Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus, avian flu, shingles, Clostridioides difficile, and malaria. Novavax develops proprietary immune-stimulating saponin-based immunologic adjuvants at a wholly owned Swedish subsidiary, Novavax AB. One of these, Matrix-M, is used in the Novavax COVID-19 vaccine.

Nouvelles